Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:24 PM
Ignite Modification Date:
2025-12-24 @ 9:24 PM
NCT ID:
NCT04632732
Eligibility Criteria:
Inclusion Criteria:
* For the 4 -non-control- major groups:
* Adults patients hospitalized for symptomatic acute (presumably infectious) respiratory illness
* In the 36 hours after admission.
Exclusion Criteria:
* Patients already hospitalized for more than 36 hours.
* Pediatric patients.
* Asymptomatic patients.
* Non acute respiratory illness patients.
* Primary pulmonary embolism as causative (i.e pulmonary embolism can be concomitant to respiratory symptoms related to SRAS COVID but not without).
* Exacerbated terminal/severe COPD of Pulmonary fibrosis with or without home oxygen.
* Patients with indirect form of ARDS.
* Cystic fibrosis.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04632732
Study Brief:
Protocol Section:
NCT04632732